SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today announced groundbreaking new findings from an in-vitro study demonstrating that the Steripath® ISDD may improve the accuracy of blood...
Hence then, the article about new study demonstrates potential for enhanced accuracy of blood cultures with steripath initial specimen diversion device isdd for central line draws was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws )
Also on site :
- Manchester United vs Newcastle Prediction: Heavyweights Meet in Premier League’s Only Boxing Day Clash
- Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
- My Daughter’s Friend Has a Crush on My Husband. It’s Making Us Both Deeply Uncomfortable.